Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia.
Loma Therapeutics has raised $45K in total funding. The most recent round was Grant. The last funding was announced in June 2024.
Loma Therapeutics's investors include BioInnovation Institute, Merck.
Loma Therapeutics is headquartered in Copenhagen, Denmark.
Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia.
Loma Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Loma Therapeutics — Funding & Investors." VCBacked, June 24, 2024, https://www.vcbacked.co/company/loma-therapeutics. Accessed August 15, 2026.
VCBacked. (2024). Loma Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/loma-therapeutics
{{cite web |title=Loma Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/loma-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated